Mediterranean visceral leishmaniasis in pregnancy

Scand J Infect Dis. 1994;26(5):627-9. doi: 10.3109/00365549409011824.

Abstract

Visceral leishmaniasis (VL) in pregnancy is rare in Mediterranean countries. We report here 2 cases of VL in pregnant women who acquired the infection in Italy. In the first case, the disease was diagnosed and treated with liposomal amphotericin B during the pregnancy. In the second case, diagnosis was established and treatment with meglumine antimoniate both undertaken shortly after delivery. The 2 infants were followed clinically and serologically for 8-9 months after birth, but no evidence of congenital VL was observed.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphotericin B / therapeutic use
  • Animals
  • Antibodies, Protozoan / biosynthesis*
  • Antiprotozoal Agents / therapeutic use
  • Female
  • Humans
  • Infant, Newborn
  • Italy
  • Leishmania infantum / immunology*
  • Leishmaniasis, Visceral / diagnosis*
  • Leishmaniasis, Visceral / drug therapy*
  • Meglumine / therapeutic use
  • Meglumine Antimoniate
  • Organometallic Compounds / therapeutic use
  • Pregnancy
  • Pregnancy Complications, Parasitic / diagnosis*
  • Pregnancy Complications, Parasitic / drug therapy*
  • Serologic Tests

Substances

  • Antibodies, Protozoan
  • Antiprotozoal Agents
  • Organometallic Compounds
  • Meglumine
  • Meglumine Antimoniate
  • Amphotericin B